(180)Nakase H., Okazaki K., Tabata Y., Uose S., Ohana M., Uchida K., Matsushima Y., Kawanami C., Oshima C., Ikada Y., Chiba T.
Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy
J Pharmacol Exp Ther, 292, 15-21, (2000)

(181)Morimoto K., Katsumata H., Yabuta T., Iwanaga K., Kakemi M., Tabata Y., Ikada Y.
Gelatin microspheres as a pulmonary delivery system: evaluation of salmon calcitonin absorption
J Pharm Pharmacol, 52, 611-7, (2000)

(182)仲瀬 裕志, 岡崎 和一, 河南 智晴, 千葉 勉, 田畑 泰彦, 筏 義人
Microsphereを用いた新しい経口治療法
臨床消化器内科, 30, 426-30, (2000)

(183)John A., Tabata Y., Yamamoto Y., Sivakumar R., Ikada Y.
A trial to prepare collagen-hydroxyapatite composite in vitro.
Biomedical Materials Research in the Asian (IV), 91-2, (2000)

(184)Hong L., Tabata Y., Miyamoto S., Yamamoto M., Yamada K., Hashimoto N., Ikada Y.
Bone regeneration at rabbit skull defects treated with transforming growth factor-beta1 incorporated into hydrogels with different levels of biodegradability
J Neurosurg, 92, 315-25, (2000)

(185)Yamamoto M., Tabata Y., Hong L., Miyamoto S., Hashimoto N., Ikada Y.
Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel
J Control Release, 64, 133-42, (2000)

(186)Yang C. F., Yasukawa T., Kimura H., Miyamoto H., Honda Y., Tabata Y., Ikada Y., Ogura Y.
Experimental corneal neovascularization by basic fibroblast growth factor incorporated into gelatin hydrogel
Ophthalmic Res, 32, 19-24, (2000)

(187)Yamamoto M., Tabata Y., Kawasaki H., Ikada Y.
Promotion of fibrovascular tissue ingrowth into porous sponges by basic fibroblast growth factor
J Mater Sci Mater Med, 11, 213-8, (2000)

(188)河合 勝也, 鈴木 茂彦, 田畑 泰彦, 平 嗣良, 筏 義人, 西村 善彦
抗菌性人工真皮の開発 ―in vitroにおける評価―
日本熱傷学会誌, 26, 35-45, (2000)

(189)Tabata Y., Miyao M., Inamoto T., Ishii T., Hirano Y., Yamaoki Y., Ikada Y.
De novo formation of adipose tissue by controlled release of basic fibroblast growth factor
Tissue Eng, 6, 279-89, (2000)

(190)Kawai K., Suzuki S., Tabata Y., Ikada Y., Nishimura Y.
Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis
Biomaterials, 21, 489-99, (2000)

(191)Hong L., Tabata Y., Miyamoto S., Yamada K., Aoyama I., Tamura M., Hashimoto N., Ikada Y.
Promoted bone healing at a rabbit skull gap between autologous bone fragment and the surrounding intact bone with biodegradable microspheres containing transforming growth factor-beta1
Tissue Eng, 6, 331-40, (2000)

(192)Tabata Y., Yamamoto M., Ikada Y.
Bone regeneration at rabbit skull defects by biodegradable hydrogels incorporating transforming growth factor beta-1.
Biomedical Materials Research in the Asian (IV), 24-25, (2000)

(193)Yamamoto M., Tabata Y., Ikada Y.
Controlled release of growth factors from a biodegradable hydrogel for tissue engineering.
Biomedical Materials Research in the Asian (IV), 41-2, (2000)

(194)Kawai K., Suzuki S., Tabata Y., Ikada Y., Nishimura Y.
Evaluation of basic fibroblast growth factor-impregnated gelatin microspheres incorporated into an artificial dermis.
Biomedical Materials Research in the Asian (IV), 146-7, (2000)

(195)Tabata Y., Miyao M., Yamamoto M., Ikada Y.
Vascularization into a porous scaffold through controlled release of basic fibroblast growth factor.
Biomedical Materials Research in the Asian (IV), 148-9, (2000)

(196)Tabata Y., Ishii T., Muniruzzaman M., Hirano Y., Ikada Y.
Influence of gelatin complexation on cell proliferation activity and proteolytic resistance of basic fibroblast growth factor
J Biomater Sci Polym Ed, 11, 571-82, (2000)

(197)Muniruzzaman M., Tabata Y., Ikada Y.
Physicochemical properties of basic fibroblast growth factor-gelatin complex
Journal of Bioactive and Compatible Polymers, 15, 365-375, (2000)

(198)Tabata Y., Miyao M., Ozeki M., Ikada Y.
Controlled release of vascular endothelial growth factor released by use of collagen hydrogels.
J Biomater Sci Polym Ed, 11, 915-30, (2000)

(199)Tabata Y., Hong L., Miyamoto S., Miyao M., Hashimoto N., Ikada Y.
Bone formation at a rabbit skull defect by autologous bone marrow cells combined with gelatin microspheres containing TGF-beta1
J Biomater Sci Polym Ed, 11, 891-901, (2000)

(200)田畑 泰彦
生体適合性材料と再生医療 特集 21世紀における再生医療の役割
BIO INDUSTRY, 17, 5-11, (2000)

(201)Ikada Y., Tabata Y.
Growth factor release from biodegradable hydrogels to induce neovascularization.
Handbook of Pharmaceutical Controlled Release Technology, 725-42, (2000)

(202)田畑 泰彦
腸管免疫とワクチン
臨床消化器免疫, 15, 323-9, (2000)

(203)田畑 泰彦
再生医学の応用の現状と課題、マトリックスとDDS 特集 再生医学と21世紀の医療;その進歩と課題
Pharma Medica, 18, 69-74, (2000)

(204)山本 雅哉, 田畑 泰彦, 筏 義人
組織と器官 異所性の骨形成
バイオミメティックハンドブック, 441-4, (2000)

(205)山本 雅哉, 田畑 泰彦, 筏 義人
組織再生のための細胞成長因子のゼラチンハイドロゲルからの徐放
生体材料, 18, 194-200, (2000)

(206)田畑 泰彦
金属の生体への影響 -異物反応の基礎-
金属系バイオマテリアルの基礎と応用, 335-46, (2000)

(207)田畑 泰彦, 筏 義人
超音波による薬物の作用増強
ケミカル・エンジニアリング, 254-257, (2000)

(208)田畑 泰彦
ドラッグデリバリーシステム
蛋白質・核酸・酵素, 45, 2179-87, (2000)

(209)Tabata Y.
The importance of drug delivery systems in tissue engineering.
Pharmaceutical Science and Technology Today, 3, 80-9, (2000)

(210)田畑 泰彦
細胞成長因子の徐放化
BIO Clinica, 15, 19-23, (2000)

(211)田畑 泰彦
歯周組織の再生医学: 歯周病 新しい治療を求めて
先端医療シリーズ・歯科医学2, (2000)

(212)田畑 泰彦
日本DDS学会 基礎医学研究者の立場から
Drug Delivery System, 15, 538-9, (2000)

(213)田畑 泰彦
組織工学 -この一年の進歩-
人工臓器, 29, 614-5, (2000)

(214)田畑 泰彦
DDSとバイオマテリアル
生体材料, 18, 270-2, (2000)

(215)Tabata Y.
Neccesity of drug delivery systems to tissue engineering
Biomaterials and Drug Delivery Toward New Millenium., 531-44, (2000)

(216)山本 雅哉, 田畑 泰彦
循環器領域の再生医学
ハートナーシング, 13, 71-8, (2000)

(217)Iwakura A., Tabata Y., Miyao M., Ozeki M., Tamura N., Ikai A., Nishimura K., Nakamura T., Shimizu Y., Fujita M., Komeda M.
Novel method to enhance sternal healing after harvesting bilateral internal thoracic arteries with use of basic fibroblast growth factor
Circulation, 102, III307-11, (2000)

(218)Wang J., Tauchi Y., Deguchi Y., Morimoto K., Tabata Y., Ikada Y.
Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori
Drug Deliv, 7, 237-43, (2000)

(219)John A., Ikada Y., Tabata Y.
Effect of ultrasound exposure on mouse calvaria 3T3-E1 cells
Biomed. Eng. Appl. Basis & Comm., 12, 6-15, (2000)

(220)Iwakura A., Tabata Y., Nishimura K., Nakamura T., Shimizu Y., Fujita M., Komeda M.
Basic fibroblast growth factor may improve devascularized sternal healing.
Annals of Thoracic Surgery, 70, 824-8, (2000)

(221)Hong L., Miyamoto S., Hashimoto N., Tabata Y.
Synergistic effect of gelatin microspheres incorporating TGF-beta1 and a physical barrier for fibrous tissue infiltration on skull bone formation
J Biomater Sci Polym Ed, 11, 1357-69, (2000)

(222)Yasukawa T., Kimura H., Tabata Y., Miyamoto H., Honda Y., Ikada Y., Ogura Y.
Active drug targeting with immunoconjugates to chroidal neovascularization
Curr. Eye Res., 21, 952-961, (2000)